The Effect of Oat Processing on Gastric Emptying and Satiety Induced After Consuming Porridge
Launched by QUADRAM INSTITUTE BIOSCIENCE · Jan 13, 2016
Trial Information
Current as of April 28, 2025
Completed
Keywords
ClinConnect Summary
Eight participants will be recruited onto the study via the Human Nutrition Unit (HNU) Volunteer Database, advertising fliers and social media. Potential participants will be invited to IFR for a talk about the study, followed by health screening if they wish to participate. Written, informed consent will be taken by a member of the research team prior to undertaking any study related procedures.
Each participant will undergo 2 study days (min.7 days apart) and they will eat 2 types of porridge in a random order. Allocation of the order of the porridge meals will be done before the partici...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Male (hormonal status of women would introduce more variation within small group)
- • Age 20-55y (people older than the upper age limit for the study, may suffer from degeneration of the GI tract, which would compromise our study data).
- • BMI 19-35 kg/m2
- • Apparently healthy
- • Normally eat lunch and breakfast
- • Willing to eat porridge type meal
- • Willing to be cannulated and have blood samples taken
- • Be able provide written informed consent
- Exclusion Criteria:
- Potential participants will be excluded if:
- • They are line managed or supervised by any members of the study team either at IFR or NNUHFT Radiology.
- • They are a student with a dependency on any member of the NNUHFT/ IFR study team.
- • They are related to or living with any member of the study team (NNUHFT or IFR).
- • They have an intense dislike of/ intolerance / allergy to any of the constituents of the test meal.
- • They are smokers or have smoked within the last year (smoking affects satiety/hunger); this also includes e-cigarettes.
- • They have been diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease.
- • They have had surgery on the stomach or intestine or suffered from oesophageal or gastrointestinal disease, whether diagnosed or self-reported.
- • They currently suffer from, or have suffered from an eating disorder.
- • They are taking antibiotics on a long-term basis.
- • They regularly (more than once in 10 days) use antacids, laxatives.
- • They have any problems with swallowing.
- • They take prescribed or over the counter medication for digestive or gastrointestinal conditions.
- • They are receiving anticoagulant therapy or have finished anticoagulant therapy within the previous week.
- • They are taking any dietary supplements/ herbal remedies which may affect the study data unless they are willing to stop taking within the appropriate timescale for the study. These will be assessed on an individual basis.
- • They are currently using Ginko supplements (unless the individual is willing to stop taking the supplements for a minimum of 1 week before screening and for the duration of the study).
- • They are taking part in another research study (other than a questionnaire based study).
- • Their blood pressure greater than 160/100 mmHg or less than 90/50 or 95/55 mmHg if symptomatic.
- • They have any special dietary requirements (e.g. dairy-free).
- • They have participated in a research study during the previous four months where the combined blood sampling from previous study and this study would exceed 470 ml.
- • Any of the clinical screening results are indicative of a health problem which could affect the participants' well-being or which would affect the study data if they took part.
- • The HbA1c result greater than 42 mmol/ ml.
- • They are unwilling or unable to provide GP details.
- • They refuse to give permission to inform GP of participation in study.
- • They are not registered with a GP in the UK
- • They have recently experienced unexplained weight gain or loss.
- • They have a history of back problems or any other condition which limit ability to repeatedly sit up and lie down.
- • They have a Hiatus Hernia.
- MRI scanning specific exclusion criteria:
- Potential participants will also be excluded from the study if they:
- • Have a cardiac pacemaker or artificial heart valve.
- • Have had any surgery in the last 6 months.
- • Have aneurysm clips (metal clips from surgery).
- • Have an implant, pump or any medical device in the body (e.g. cochlear implant, neurostimulator, intra-venticular shunt).
- • Have worked with metals (using lathes or grinders) or sustained injury to eyes involving metal splinters or fillings.
- • Have artificial eyes or limbs.
- • Have been injured with shrapnel or bullets.
- • Have a metal tattoo.
- • Suffer from fits, blackouts or epilepsy.
- • Suffer from claustrophobia.
- Clinical screening exclusion criteria:
- • Potential participants will be excluded if clinical screening results deemed by the HNU Medical Advisor, to be indicative of a health problem which may compromise the well-being of the participant, or which could affect the study data.
About Quadram Institute Bioscience
Quadram Institute Bioscience is a leading research organization dedicated to enhancing human health through innovative scientific discovery and collaboration. Focusing on the complex interactions between diet, gut microbiota, and health, the institute undertakes cutting-edge clinical trials and translational research aimed at understanding and addressing gastrointestinal diseases and their broader implications for overall well-being. With a multidisciplinary team of experts, Quadram Institute Bioscience is committed to advancing knowledge in microbiome research, nutritional science, and health innovation, ultimately translating findings into effective clinical applications and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Norwich, Norfolk, United Kingdom
Patients applied
Trial Officials
Alan R Mackie, PhD
Principal Investigator
Quadram Institute Bioscience
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials